Sort
82,697 grants matching “vaccine development”
BASE TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND ENDPOINT BIOMARKERS; TASK ORDER TITLE: EFGR AND KRAS VACCINE
$890,873Chinthalapally V. Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2020 · CA
ADOLESCENT TRIAL NETWORK FOR HIV/AIDS BALTIMORE
$890,809University Of Maryland Baltimore · U01 · FY2004 · HD
Novel mechanisms regulating immunity to respiratory virus infection
$890,660Silke Paust · Jackson Laboratory · R01 · FY2024 · AI
Rapid Portable HIV Detection and Monitoring System for Low Resource Settings
$890,573Joel W. Grover · Thermal Gradient, Inc. · R44 · FY2012 · AI
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection
$890,560John A Moss · Oak Crest Institute Of Science · R01 · FY2023 · AI
Defining Drivers of HPV-associated Carcinogenesis
$890,460Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2019 · CA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$890,425Pamela J Bjorkman · California Institute Of Technology · P01 · FY2024 · AI
A Neonatal Monkey Model for Tuberculosis Vaccination
$890,384Chinnaswamy Jagannath · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · AI
Core 1 - Structural Biology Core
$890,349Priyamvada Acharya · Duke University · U54 · FY2022 · AI
Cancer Immunotherapy Clinical Trials
$890,340Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers
$890,180D. Noah Sather · Seattle Children'S Hospital · R01 · FY2020 · AI
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers
$890,180D. Noah Sather · Seattle Children'S Hospital · R01 · FY2021 · AI
Papillomavirus Virion Proteins and Vaccines
$890,103Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
$890,058Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2019 · AI
Molecular Genetics Of Scrapie Pathogenesis
$889,806Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
$889,638Roger L Shapiro · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2025 · AI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$889,528Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2013 · DE
Phase II Clinical Trial to Evaluate a Vaccine Candidate for Gonorrhea (Meningococcal Immunization Against Gonococcal Infection)
$889,507National Institute Of Allergy And Infectious Diseases · Y01 · FY2025 · AI
Immunology of aging and immunotherapy of aging-associated diseases
$889,306Arya Biragyn · National Institute On Aging · ZIA · FY2014 · AG
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$889,264Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Immune Correlates of Protection from TB
$889,259Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2022 · AI
EVASION OF HOST IMMUNE RESPONSE BY INFLUENZA VIRUS
$889,201Mount Sinai School Of Medicine Of Nyu · P01 · FY2001 · AI
DNA Vaccine for Induction of Mucosal Immunity
$889,109David B. Weiner · University Of Pennsylvania · P01 · FY2011 · AI
Animal Studies Core
$888,991Shixia Wang · New York University School Of Medicine · P01 · FY2015 · AI
Vaccine Studies Of Simian Immunodeficiency Virus (SIV) in Macaques
$888,890Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI